Dr. Anna-Maria Ciciliani

Position

pharmacist, teaching courses (AFL-1), GMP employee: head of quality assurance, research assistant

Field(s) of research: Respiratory drug delivery

 

Publications

Paper (2020): “Lung Deposition Using the Respimat ® Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/ In Silico Analysis”, Ciciliani A, Denny M, Langguth P, Voshaar T, Wachtel H, Journal of Chronic Obstructive Pulmonary Disease, Volume 18, Issue 1, 11 Dec 2020, Pages 91-100

Paper (2019): “Handling forces for the use of different inhaler devices”, Ciciliani A, Langguth P, Wachtel H, International Journal of Pharmacy, Volume 560, 5 April 2019, Pages 315-321

Book, ISBN: 978-620-2-32233-1 (2018): “Pharmazeutische Aerosole für pädiatische und geriatrische Patienten”, Südwestdeutscher Verlag für Hochschulschriften

Paper (2017): “In Vitro Dose Comparison of Respimat® Soft Mist™ Inhaler with Dry Powder Inhalers for COPD Maintenance Therapy”, Ciciliani A, Langguth P, Wachtel H, Dovepress: International Journal of COPD, Volume 2017:12, Pages 1565—1577

Conferences/workshops/presentations:

Poster presentation: DGP 2019: „Fingerkraftmessung bei der Bedienung von Inhalatoren“, AM Ciciliani, P Langguth, H Wachtel

Poster presentation: ISAM 2015, “Respimat® Soft Mist™ Inhaler shows higher in-vitro Deposition Performance compared to other COPD Inhalers”: Ted Martonen Student Research Award

Poster presentation: RDD 2015, “Evaluation of Respimat® Soft MistTM Inhaler based on in vitro measurements and CFD simulations”

Scientific talk: Inhaled Drug Delivery 2014, “Device Comparison based on in vitro models”

Poster presentation: RDD 2014, “Comparing Respimat® Soft MistTM Inhaler and DPI Aerosol Deposition by Combined In Vitro Measurements and CFD Simulations”

Scientific talk and poster presentation: DGP 2014, “In Vitro Dosisvergleich des Respimat® Soft Inhaler™ mit Trockenpulverinhalatoren für die COPD-Therapie”

Poster presentation: ISAM 2013, “In Vitro Dose Comparison of Respimat® Soft Mist™ Inhaler with Dry Powder Inhalers for COPD Maintenance Therapy”

Other activities

DPhG - Member